Drug Type Chemical drugs |
Synonyms |
Target |
Action modulators |
Mechanism TMEM175 modulators(transmembrane protein 175 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Preclinical | South Korea | 04 May 2024 |





